Barclays PLC Reduces Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Barclays PLC trimmed its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 27.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 382,507 shares of the real estate investment trust's stock after selling 145,566 shares during the quarter. Barclays PLC owned approximately 0.14% of Omega Healthcare Investors worth $15,568,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. State Street Corp raised its position in shares of Omega Healthcare Investors by 0.9% in the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust's stock worth $502,228,000 after acquiring an additional 114,085 shares in the last quarter. FMR LLC grew its position in shares of Omega Healthcare Investors by 9.9% during the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust's stock worth $171,625,000 after buying an additional 380,626 shares during the period. Daiwa Securities Group Inc. increased its stake in shares of Omega Healthcare Investors by 317.7% in the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock valued at $160,739,000 after acquiring an additional 3,003,845 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Omega Healthcare Investors by 6.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust's stock valued at $155,893,000 after purchasing an additional 240,006 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock worth $127,831,000 after purchasing an additional 272,299 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company's stock.

Omega Healthcare Investors Stock Down 0.6 %

Shares of Omega Healthcare Investors stock traded down $0.23 during trading on Monday, reaching $38.99. The company's stock had a trading volume of 1,408,026 shares, compared to its average volume of 1,686,828. The company has a 50-day simple moving average of $40.37 and a two-hundred day simple moving average of $38.02. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The company has a market cap of $10.52 billion, a price-to-earnings ratio of 28.67, a P/E/G ratio of 1.22 and a beta of 0.98. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.87%. Omega Healthcare Investors's dividend payout ratio is currently 197.06%.

Insider Buying and Selling at Omega Healthcare Investors

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company's stock, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

OHI has been the topic of a number of analyst reports. Truist Financial upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, September 4th. Mizuho upped their price target on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a report on Thursday, December 5th. Wells Fargo & Company restated an "overweight" rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 target price for the company in a report on Monday, December 9th. Finally, Scotiabank upped their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research report on Monday, August 26th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $40.18.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.